1: Falck RS, Hsu CL, Silva NCBS, Li LC, Best JR, Liu-Ambrose T. The independent
associations of physical activity and sleep with neural activity during an
inhibitory task: cross-sectional results from the MONITOR-OA study. J Sleep Res.
2022 Jul 12:e13692. doi: 10.1111/jsr.13692. Epub ahead of print. PMID: 35821379.

2: Imabayashi E, Tamamura N, Yamaguchi Y, Kamitaka Y, Sakata M, Ishii K.
Automated semi-quantitative amyloid PET analysis technique without MR images for
Alzheimer's disease. Ann Nucl Med. 2022 Oct;36(10):865-875. doi:
10.1007/s12149-022-01769-x. Epub 2022 Jul 11. PMID: 35821311; PMCID: PMC9515054.

3: Wojcieszak J, Kuczyńska K, Zawilska JB. Role of Chemokines in the Development
and Progression of Alzheimer's Disease. J Mol Neurosci. 2022
Sep;72(9):1929-1951. doi: 10.1007/s12031-022-02047-1. Epub 2022 Jul 12. PMID:
35821178; PMCID: PMC9392685.

4: Kim HJ, Oh JS, Lim JS, Lee S, Jo S, Chung EN, Shim WH, Oh M, Kim JS, Roh JH,
Lee JH; Alzheimer’s Disease Neuroimaging Initiative. The impact of subthreshold
levels of amyloid deposition on conversion to dementia in patients with amyloid-
negative amnestic mild cognitive impairment. Alzheimers Res Ther. 2022 Jul
11;14(1):93. doi: 10.1186/s13195-022-01035-2. PMID: 35821150; PMCID: PMC9277922.

5: Xia P, Chen J, Liu Y, Cui X, Wang C, Zong S, Wang L, Lu Z. MicroRNA-22-3p
ameliorates Alzheimer's disease by targeting SOX9 through the NF-κB signaling
pathway in the hippocampus. J Neuroinflammation. 2022 Jul 12;19(1):180. doi:
10.1186/s12974-022-02548-1. PMID: 35821145; PMCID: PMC9277852.

6: Wang C, Zhang Y, Zhao D, Huo Y, Xie J, Zhang X, Luo H, Xu H, Zhang YW.
Phenazopyridine promotes RPS23RG1/Rps23rg1 transcription and ameliorates
Alzheimer-associated phenotypes in mice. Neuropsychopharmacology. 2022 Jul 11.
doi: 10.1038/s41386-022-01373-7. Epub ahead of print. PMID: 35821069.

7: Carvalho K, Schartz ND, Balderrama-Gutierrez G, Liang HY, Chu SH, Selvan P,
Gomez-Arboledas A, Petrisko TJ, Fonseca MI, Mortazavi A, Tenner AJ. Modulation
of C5a-C5aR1 signaling alters the dynamics of AD progression. J
Neuroinflammation. 2022 Jul 11;19(1):178. doi: 10.1186/s12974-022-02539-2. PMID:
35820938; PMCID: PMC9277945.

8: Montero-Odasso M, Zou GY, Kamkar N, Feldman HH, Belleville S, Chertkow H,
Nygaard HB, Son S, Speechley M. Multidomain trials to prevent dementia:
addressing methodological challenges. Alzheimers Res Ther. 2022 Jul 11;14(1):94.
doi: 10.1186/s13195-022-01036-1. PMID: 35820915; PMCID: PMC9275261.

9: Ruver-Martins AC, Bicca MA, de Araujo FS, de Noronha Sales Maia BHL, Pamplona
FA, da Silva EG, Nascimento FP. Cannabinoid extract in microdoses ameliorates
mnemonic and nonmnemonic Alzheimer's disease symptoms: a case report. J Med Case
Rep. 2022 Jul 12;16(1):277. doi: 10.1186/s13256-022-03457-w. PMID: 35820856;
PMCID: PMC9277875.

10: Hok-A-Hin YS, Dijkstra AA, Rábano A, Hoozemans JJ, Castillo L, Seelaar H,
van Swieten JC, Pijnenburg YAL, Teunissen CE, Del Campo M. Apolipoprotein L1 is
increased in frontotemporal lobar degeneration post-mortem brain but not in
ante-mortem cerebrospinal fluid. Neurobiol Dis. 2022 Oct 1;172:105813. doi:
10.1016/j.nbd.2022.105813. Epub 2022 Jul 9. PMID: 35820647.

11: Jin SX, Liu L, Li S, Meunier AL, Selkoe DJ. Aβ oligomers from human brain
impair mossy fiber LTP in CA3 of hippocampus, but activating cAMP-PKA and cGMP-
PKG prevents this. Neurobiol Dis. 2022 Oct 1;172:105816. doi:
10.1016/j.nbd.2022.105816. Epub 2022 Jul 9. PMID: 35820646.

12: Sontag JM, Schuhmacher D, Taleski G, Jordan A, Khan S, Hoffman A, Gomez RJ,
Mazalouskas MD, Hanks SK, Spiller BW, Sontag E, Wadzinski BE. A new paradigm for
regulation of protein phosphatase 2A function via Src and Fyn kinase-mediated
tyrosine phosphorylation. J Biol Chem. 2022 Aug;298(8):102248. doi:
10.1016/j.jbc.2022.102248. Epub 2022 Jul 9. PMID: 35820485; PMCID: PMC9396060.

13: Shiosaka S. Kallikrein 8: A key sheddase to strengthen and stabilize neural
plasticity. Neurosci Biobehav Rev. 2022 Sep;140:104774. doi:
10.1016/j.neubiorev.2022.104774. Epub 2022 Jul 9. PMID: 35820483.

14: Wei YC, Chen CK, Lin C, Chen PY, Hsu PC, Lin CP, Shyu YC, Huang WY.
Normative Data of Mini-Mental State Examination, Montreal Cognitive Assessment,
and Alzheimer's Disease Assessment Scale-Cognitive Subscale of Community-
Dwelling Older Adults in Taiwan. Dement Geriatr Cogn Disord. 2022 Jul 12:1-12.
doi: 10.1159/000525615. Epub ahead of print. PMID: 35820405.

15: Honjo Y, Kawasaki I, Nagai K, Harada S, Ogawa N. Neuropsychiatric Inventory
Questionnaire Associated with Cognitive Function, Age, and Duration of Education
in Patients with Alzheimer's Disease. Dement Geriatr Cogn Disord.
2022;51(3):285-290. doi: 10.1159/000525670. Epub 2022 Jul 12. PMID: 35820373.

16: Zicha S, Bateman RJ, Shaw LM, Zetterberg H, Bannon AW, Horton WA, Baratta M,
Kolb HC, Dobler I, Mordashova Y, Saad ZS, Raunig DL, Spanakis EM, Li Y,
Schindler SE, Ferber K, Rubel CE, Martone RL, Weber CJ, Edelmayer RM, Meyers EA,
Bollinger JG, Rosenbaugh EG, Potter WZ; Alzheimer's Disease Neuroimaging
Initiative (ADNI); Foundation for the National Institutes of Health (FNIH)
Biomarkers Consortium Plasma Aβ as a Predictor of Amyloid Positivity in
Alzheimer's Disease Project Team. Comparative analytical performance of multiple
plasma Aβ42 and Aβ40 assays and their ability to predict positron emission
tomography amyloid positivity. Alzheimers Dement. 2022 Jul 12. doi:
10.1002/alz.12697. Epub ahead of print. PMID: 35820077.

17: Wang JT, Xu G, Ren RJ, Wang Y, Tang R, Huang Q, Li JP, Al-Nusaif M, Le WD,
Wang G. The impacts of health insurance and resource on the burden of
Alzheimer's disease and related dementias in the world population. Alzheimers
Dement. 2022 Jul 12. doi: 10.1002/alz.12730. Epub ahead of print. PMID:
35820032.

18: Patil AD, Biousse V, Newman NJ. Artificial intelligence in ophthalmology: an
insight into neurodegenerative disease. Curr Opin Ophthalmol. 2022 Sep
1;33(5):432-439. doi: 10.1097/ICU.0000000000000877. Epub 2022 Jul 12. PMID:
35819902.

19: Lee J, Ye Y. Studying Unconventional Secretion of Misfolded Proteins in
Cultured Cells and Primary Neurons. Methods Mol Biol. 2022;2473:349-366. doi:
10.1007/978-1-0716-2209-4_22. PMID: 35819775.

20: Grey MT, Mitterová K, Gajdoš M, Uher R, Klobušiaková P, Rektorová I, Rektor
I. Differential spatial distribution of white matter lesions in Parkinson's and
Alzheimer's diseases and cognitive sequelae. J Neural Transm (Vienna). 2022
Aug;129(8):1023-1030. doi: 10.1007/s00702-022-02519-z. Epub 2022 Jul 11. PMID:
35819634.

21: Gautam V, Gaurav A, Masand N, Lee VS, Patil VM. Artificial intelligence and
machine-learning approaches in structure and ligand-based discovery of drugs
affecting central nervous system. Mol Divers. 2022 Jul 11. doi:
10.1007/s11030-022-10489-3. Epub ahead of print. PMID: 35819579.

22: Hallinan GI, Ozcan KA, Hoq MR, Cracco L, Vago FS, Bharath SR, Li D, Jacobsen
M, Doud EH, Mosley AL, Fernandez A, Garringer HJ, Jiang W, Ghetti B, Vidal R.
Cryo-EM structures of prion protein filaments from Gerstmann-Sträussler-
Scheinker disease. Acta Neuropathol. 2022 Sep;144(3):509-520. doi:
10.1007/s00401-022-02461-0. Epub 2022 Jul 12. PMID: 35819518; PMCID: PMC9381446.

23: Kapoor R, Saini A, Sharma D. Indispensable role of microbes in anticancer
drugs and discovery trends. Appl Microbiol Biotechnol. 2022
Aug;106(13-16):4885-4906. doi: 10.1007/s00253-022-12046-2. Epub 2022 Jul 11.
PMID: 35819512.

24: Freckelton I. Parkinson's Disease and the Criminal Justice System. J Law
Med. 2022 Jun;29(2):309-321. PMID: 35819373.

25: Wang X, Gao H, Zhang X, Qian S, Wang C, Deng L, Zhong M, Qing G. Aspartic
Acid-Modified Phospholipids Regulate Cell Response and Rescue Memory Deficits in
APP/PS1 Transgenic Mice. ACS Chem Neurosci. 2022 Jul 20;13(14):2154-2163. doi:
10.1021/acschemneuro.2c00202. Epub 2022 Jul 12. PMID: 35818957.

26: Huang L, Liu Z, Li Y. Incompleteness features in the descriptive discourse
of Chinese elders with and without <i>Alzheimer</i>'s disease. Clin Linguist
Phon. 2022 Jul 12:1-16. doi: 10.1080/02699206.2022.2092423. Epub ahead of print.
PMID: 35818887.

27: Serrano GE, Walker JE, Tremblay C, Piras IS, Huentelman MJ, Belden CM,
Goldfarb D, Shprecher D, Atri A, Adler CH, Shill HA, Driver-Dunckley E, Mehta
SH, Caselli R, Woodruff BK, Haarer CF, Ruhlen T, Torres M, Nguyen S, Schmitt D,
Rapscak SZ, Bime C, Peters JL, Alevritis E, Arce RA, Glass MJ, Vargas D, Sue LI,
Intorcia AJ, Nelson CM, Oliver J, Russell A, Suszczewicz KE, Borja CI, Cline MP,
Hemmingsen SJ, Qiji S, Hobgood HM, Mizgerd JP, Sahoo MK, Zhang H, Solis D,
Montine TJ, Berry GJ, Reiman EM, Röltgen K, Boyd SD, Pinsky BA, Zehnder JL,
Talbot P, Desforges M, DeTure M, Dickson DW, Beach TG. SARS-CoV-2 Brain Regional
Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in
Decedents with COVID-19. J Neuropathol Exp Neurol. 2022 Aug 16;81(9):666-695.
doi: 10.1093/jnen/nlac056. PMID: 35818336; PMCID: PMC9278252.

28: Ishii A, Matsuba Y, Mihira N, Kamano N, Saito T, Muramatsu SI, Yokosuka M,
Saido TC, Hashimoto S. Tau-binding protein PRMT8 facilitates vacuole
degeneration in the brain. J Biochem. 2022 Jul 11:mvac058. doi:
10.1093/jb/mvac058. Epub ahead of print. PMID: 35818334.

29: Han J, Yoon J, Shin J, Nam E, Qian T, Li Y, Park K, Lee SH, Lim MH.
Conformational and functional changes of the native neuropeptide somatostatin
occur in the presence of copper and amyloid-β. Nat Chem. 2022
Sep;14(9):1021-1030. doi: 10.1038/s41557-022-00984-3. Epub 2022 Jul 11. PMID:
35817963.

30: Perovnik M, Tomše P, Jamšek J, Emeršič A, Tang C, Eidelberg D, Trošt M.
Identification and validation of Alzheimer's disease-related metabolic brain
pattern in biomarker confirmed Alzheimer's dementia patients. Sci Rep. 2022 Jul
11;12(1):11752. doi: 10.1038/s41598-022-15667-9. PMID: 35817836; PMCID:
PMC9273623.

31: Yan T, Liang J, Gao J, Wang L, Fujioka H; Alzheimer Disease Neuroimaging
Initiative, Zhu X, Wang X. Author Correction: FAM222A encodes a protein which
accumulates in plaques in Alzheimer's disease. Nat Commun. 2022 Jul
11;13(1):4006. doi: 10.1038/s41467-022-31711-8. Erratum for: Nat Commun. 2020
Jan 21;11(1):411. PMID: 35817794; PMCID: PMC9273589.

32: Kelly AG, Panigrahy D. Targeting Angiogenesis via Resolution of
Inflammation. Cold Spring Harb Perspect Med. 2022 Jul 11:a041172. doi:
10.1101/cshperspect.a041172. Epub ahead of print. PMID: 35817542.

33: Chen H, Xiao M, He J, Zhang Y, Liang Y, Liu H, Zhang Z. Aptamer-
Functionalized Carbon Nanotube Field-Effect Transistor Biosensors for
Alzheimer's Disease Serum Biomarker Detection. ACS Sens. 2022 Jul
22;7(7):2075-2083. doi: 10.1021/acssensors.2c00967. Epub 2022 Jul 11. PMID:
35816677.

34: Khatua P, Gupta M, Bandyopadhyay S. Exploring Heterogeneous Dynamical
Environment around an Ensemble of Aβ<sub>42</sub> Peptide Monomer Conformations.
J Chem Inf Model. 2022 Jul 25;62(14):3453-3462. doi: 10.1021/acs.jcim.2c00593.
Epub 2022 Jul 11. PMID: 35816665.

35: Ano Y, Takaichi Y, Ohya R, Uchida K, Nakayama H, Takashima A. Tryptophan-
tyrosine dipeptide improves tau-related symptoms in tauopathy mice. Nutr
Neurosci. 2022 Jul 11:1-12. doi: 10.1080/1028415X.2022.2090075. Epub ahead of
print. PMID: 35816407.

36: Fracassi A, Marcatti M, Tumurbaatar B, Woltjer R, Moreno S, Taglialatela G.
TREM2-induced activation of microglia contributes to synaptic integrity in
cognitively intact aged individuals with Alzheimer's neuropathology. Brain
Pathol. 2022 Jul 11:e13108. doi: 10.1111/bpa.13108. Epub ahead of print. PMID:
35816404.

37: Musiek ES, Ju YS. Targeting Sleep and Circadian Function in the Prevention
of Alzheimer Disease. JAMA Neurol. 2022 Sep 1;79(9):835-836. doi:
10.1001/jamaneurol.2022.1732. PMID: 35816332.

38: Hickman SE, Mitchell SL, Hanson LC, Tu W, Stump TE, Unroe KT. The design and
conduct of a pragmatic cluster randomized trial of an advance care planning
program for nursing home residents with dementia. Clin Trials. 2022 Jul
10:17407745221108992. doi: 10.1177/17407745221108992. Epub ahead of print. PMID:
35815777.

39: He Z, Liu D, Liu Y, Li X, Shi W, Ma H. Golgi-Targeted Fluorescent Probe for
Imaging NO in Alzheimer's Disease. Anal Chem. 2022 Jul 19;94(28):10256-10262.
doi: 10.1021/acs.analchem.2c01885. Epub 2022 Jul 10. PMID: 35815650.

40: Maulden A. Ignoring the Experts: Implications of the FDA's Aduhelm Approval.
Am J Law Med. 2022 Mar;48(1):108-133. doi: 10.1017/amj.2022.15. PMID: 35815585.

41: Alarcón-Enos J, Muñoz-Núñez E, Gutiérrez M, Quiroz-Carreño S, Pastene-
Navarrete E, Céspedes Acuña C. Dyhidro-β-agarofurans natural and synthetic as
acetylcholinesterase and COX inhibitors: interaction with the peripheral anionic
site (AChE-PAS), and anti-inflammatory potentials. J Enzyme Inhib Med Chem. 2022
Dec;37(1):1845-1856. doi: 10.1080/14756366.2022.2091554. PMID: 35815566; PMCID:
PMC9278454.

42: Bodryzlova Y, Kim A, Michaud X, André C, Bélanger E, Moullec G. Social class
and the risk of dementia: A systematic review and meta-analysis of the
prospective longitudinal studies. Scand J Public Health. 2022 Jul
10:14034948221110019. doi: 10.1177/14034948221110019. Epub ahead of print. PMID:
35815546.

43: Chen H, Deng C, Meng Z, Meng S. Effects of Catalpol on Alzheimer's Disease
and Its Mechanisms. Evid Based Complement Alternat Med. 2022 Jun
30;2022:2794243. doi: 10.1155/2022/2794243. PMID: 35815283; PMCID: PMC9262514.

44: Fei DQ, Li HH, Chen XH, Cui WB, Zhang ZP, Zhan XQ, Wang MJ, Qi FM, Zhang ZX,
Li EW. Caesalpinbondin A, a Novel Diterpenoid Lactone With an Unprecedented
Carbon Skeleton from the Seeds of <i>Caesalpinia bonduc</i>. Front Chem. 2022
Jun 24;10:911543. doi: 10.3389/fchem.2022.911543. PMID: 35815214; PMCID:
PMC9263540.

45: Dou SH, Cui Y, Huang SM, Zhang B. The Role of Brain-Derived Neurotrophic
Factor Signaling in Central Nervous System Disease Pathogenesis. Front Hum
Neurosci. 2022 Jun 24;16:924155. doi: 10.3389/fnhum.2022.924155. PMID: 35814950;
PMCID: PMC9263365.

46: Kalita S, Kalita S, Kawa AH, Shill S, Gupta A, Kumar S, Mandal B. Copper
chelating cyclic peptidomimetic inhibits Aβ fibrillogenesis. RSC Med Chem. 2022
May 9;13(6):761-774. doi: 10.1039/d2md00019a. PMID: 35814930; PMCID: PMC9215124.

47: Shamsi A, DasGupta D, Alhumaydhi FA, Khan MS, Alsagaby SA, Al Abdulmonem W,
Hassan MI, Yadav DK. Inhibition of MARK4 by serotonin as an attractive
therapeutic approach to combat Alzheimer's disease and neuroinflammation. RSC
Med Chem. 2022 Apr 20;13(6):737-745. doi: 10.1039/d2md00053a. PMID: 35814926;
PMCID: PMC9215163.

48: Chu CT. Mitochondria in neurodegeneration. Curr Opin Physiol. 2022
Apr;26:100532. doi: 10.1016/j.cophys.2022.100532. Epub 2022 Apr 1. PMID:
35814636; PMCID: PMC9267649.

49: Coffin C, Suerken CK, Bateman JR, Whitlow CT, Williams BJ, Espeland MA,
Sachs BC, Cleveland M, Yang M, Rogers S, Hayden KM, Baker LD, Williamson J,
Craft S, Hughes TM, Lockhart SN. Vascular and microstructural markers of
cognitive pathology. Alzheimers Dement (Amst). 2022 Jul 6;14(1):e12332. doi:
10.1002/dad2.12332. PMID: 35814618; PMCID: PMC9257520.

50: Abdelhak A, Solomon I, Montes SC, Saias A, Cordano C, Asken B, Fonseca C,
Oertel FC, Arfanakis K, Staffaroni AM, Kramer JH, Geschwind M, Miller BL, Elahi
FM, Green AJ. Retinal arteriolar parameters as a surrogate marker of
intracranial vascular pathology. Alzheimers Dement (Amst). 2022 Jul
5;14(1):e12338. doi: 10.1002/dad2.12338. PMID: 35814617; PMCID: PMC9257197.

51: Sayeed F, Rafeeq Ahmed K, Vinmathi MS, Priyadarsini AI, Gundupalli CB,
Tripathi V, Shishah W, Sundramurthy VP. Classification of Transgenic Mice by
Retinal Imaging Using SVMS. Comput Intell Neurosci. 2022 Jun 29;2022:9063880.
doi: 10.1155/2022/9063880. PMID: 35814547; PMCID: PMC9259271.

52: Li XW, Lu YY, Zhang SY, Sai NN, Fan YY, Cheng Y, Liu QS. Mechanism of Neural
Regeneration Induced by Natural Product LY01 in the 5×FAD Mouse Model of
Alzheimer's Disease. Front Pharmacol. 2022 Jun 22;13:926123. doi:
10.3389/fphar.2022.926123. PMID: 35814256; PMCID: PMC9258960.

53: Miny L, Maisonneuve BGC, Quadrio I, Honegger T. Modeling Neurodegenerative
Diseases Using <i>In Vitro</i> Compartmentalized Microfluidic Devices. Front
Bioeng Biotechnol. 2022 Jun 24;10:919646. doi: 10.3389/fbioe.2022.919646. PMID:
35813998; PMCID: PMC9263267.

54: Gu F, Ma S, Wang X, Zhao J, Yu Y, Song X. Evaluation of Feature Selection
for Alzheimer's Disease Diagnosis. Front Aging Neurosci. 2022 Jun 24;14:924113.
doi: 10.3389/fnagi.2022.924113. PMID: 35813964; PMCID: PMC9263380.

55: Cacciamani F, Godefroy V, Brambati SM, Migliaccio R, Epelbaum S,
Montembeault M. Differential Patterns of Domain-Specific Cognitive Complaints
and Awareness Across the Alzheimer's Disease Spectrum. Front Aging Neurosci.
2022 Jun 16;14:811739. doi: 10.3389/fnagi.2022.811739. PMID: 35813963; PMCID:
PMC9261482.

56: Luo J, Chen L, Huang X, Xie J, Zou C, Pan M, Mo J, Zou D. REPS1 as a
Potential Biomarker in Alzheimer's Disease and Vascular Dementia. Front Aging
Neurosci. 2022 Jun 22;14:894824. doi: 10.3389/fnagi.2022.894824. PMID: 35813961;
PMCID: PMC9257827.

57: Bouter Y, Bouter C. Selective Serotonin Reuptake Inhibitor-Treatment Does
Not Show Beneficial Effects on Cognition or Amyloid Burden in Cognitively
Impaired and Cognitively Normal Subjects. Front Aging Neurosci. 2022 Jun
23;14:883256. doi: 10.3389/fnagi.2022.883256. PMID: 35813957; PMCID: PMC9260503.

58: Tomizawa I, Nakagawa H, Sohma Y, Kanai M, Hori Y, Tomita T. Photo-
Oxygenation as a New Therapeutic Strategy for Neurodegenerative Proteinopathies
by Enhancing the Clearance of Amyloid Proteins. Front Aging Neurosci. 2022 Jun
23;14:945017. doi: 10.3389/fnagi.2022.945017. PMID: 35813952; PMCID: PMC9259952.

59: Morgan SL, Naderi P, Koler K, Pita-Juarez Y, Prokopenko D, Vlachos IS, Tanzi
RE, Bertram L, Hide WA. Most Pathways Can Be Related to the Pathogenesis of
Alzheimer's Disease. Front Aging Neurosci. 2022 Jun 24;14:846902. doi:
10.3389/fnagi.2022.846902. PMID: 35813951; PMCID: PMC9263183.

60: Wu H, Qiu W, Zhu X, Li X, Xie Z, Carreras I, Dedeoglu A, Van Dyke T, Han YW,
Karimbux N, Tu Q, Cheng L, Chen J. The Periodontal Pathogen <i>Fusobacterium
nucleatum</i> Exacerbates Alzheimer's Pathogenesis <i>via</i> Specific Pathways.
Front Aging Neurosci. 2022 Jun 23;14:912709. doi: 10.3389/fnagi.2022.912709.
PMID: 35813949; PMCID: PMC9260256.

61: Tang T, Li H, Zhou G, Gu X, Xue J. Discriminant Subspace Low-Rank
Representation Algorithm for Electroencephalography-Based Alzheimer's Disease
Recognition. Front Aging Neurosci. 2022 Jun 24;14:943436. doi:
10.3389/fnagi.2022.943436. PMID: 35813948; PMCID: PMC9263439.

62: Oblak AL, Kotredes KP, Pandey RS, Reagan AM, Ingraham C, Perkins B, Lloyd C,
Baker D, Lin PB, Soni DM, Tsai AP, Persohn SA, Bedwell AA, Eldridge K, Speedy R,
Meyer JA, Peters JS, Figueiredo LL, Sasner M, Territo PR, Sukoff Rizzo SJ,
Carter GW, Lamb BT, Howell GR. <i>Plcg2M28L</i> Interacts With High Fat/High
Sugar Diet to Accelerate Alzheimer's Disease-Relevant Phenotypes in Mice. Front
Aging Neurosci. 2022 Jun 24;14:886575. doi: 10.3389/fnagi.2022.886575. PMID:
35813947; PMCID: PMC9263289.

63: Coysh T, Mead S. The Future of Seed Amplification Assays and Clinical
Trials. Front Aging Neurosci. 2022 Jun 22;14:872629. doi:
10.3389/fnagi.2022.872629. PMID: 35813946; PMCID: PMC9257179.

64: Wei YC, Kung YC, Huang WY, Lin C, Chen YL, Chen CK, Shyu YC, Lin CP.
Functional Connectivity Dynamics Altered of the Resting Brain in Subjective
Cognitive Decline. Front Aging Neurosci. 2022 Jun 24;14:817137. doi:
10.3389/fnagi.2022.817137. PMID: 35813944; PMCID: PMC9263398.

65: Gao X, Chen Q, Yao H, Tan J, Liu Z, Zhou Y, Zou Z. Epigenetics in
Alzheimer's Disease. Front Aging Neurosci. 2022 Jun 23;14:911635. doi:
10.3389/fnagi.2022.911635. PMID: 35813941; PMCID: PMC9260511.

66: Li L, Wang W, Lian T, Guo P, He M, Zhang W, Li J, Guan H, Luo D, Zhang W,
Zhang W. The Influence of 24-h Ambulatory Blood Pressure on Cognitive Function
and Neuropathological Biomarker in Patients With Alzheimer's Disease. Front
Aging Neurosci. 2022 Jun 22;14:909582. doi: 10.3389/fnagi.2022.909582. PMID:
35813940; PMCID: PMC9257169.

67: Kelley CM, Ginsberg SD, Liang WS, Counts SE, Mufson EJ. Posterior cingulate
cortex reveals an expression profile of resilience in cognitively intact elders.
Brain Commun. 2022 Jun 21;4(4):fcac162. doi: 10.1093/braincomms/fcac162. PMID:
35813880; PMCID: PMC9263888.

68: Casagrande CC, Wiesman AI, Schantell M, Johnson HJ, Wolfson SL, O'Neill J,
Johnson CM, May PE, Swindells S, Murman DL, Wilson TW. Signatures of
somatosensory cortical dysfunction in Alzheimer's disease and HIV-associated
neurocognitive disorder. Brain Commun. 2022 Jun 23;4(4):fcac169. doi:
10.1093/braincomms/fcac169. PMID: 35813878; PMCID: PMC9260304.

69: Ammassari-Teule M. Inbred Mice Again at Stake: How the Cognitive Profile of
the Wild-Type Mouse Background Discloses Pathogenic Effects of APP Mutations.
Front Behav Neurosci. 2022 Jun 23;16:868473. doi: 10.3389/fnbeh.2022.868473.
PMID: 35813596; PMCID: PMC9260142.

70: Li X, Zhang P, Li H, Yu H, Xi Y. The Protective Effects of Zeaxanthin on
Amyloid-β Peptide 1-42-Induced Impairment of Learning and Memory Ability in
Rats. Front Behav Neurosci. 2022 Jun 23;16:912896. doi:
10.3389/fnbeh.2022.912896. PMID: 35813593; PMCID: PMC9262409.

71: Fan Z, Bin L. Will Sirtuin 2 Be a Promising Target for Neuroinflammatory
Disorders? Front Cell Neurosci. 2022 Jun 22;16:915587. doi:
10.3389/fncel.2022.915587. PMID: 35813508; PMCID: PMC9256990.

72: Konopka A, Atkin JD. The Role of DNA Damage in Neural Plasticity in
Physiology and Neurodegeneration. Front Cell Neurosci. 2022 Jun 23;16:836885.
doi: 10.3389/fncel.2022.836885. PMID: 35813507; PMCID: PMC9259845.

73: Ge X. Editorial: Chronic Inflammatory Response Accompanying Neuronal and
Axonal Degeneration Post Brain Injury. Front Cell Neurosci. 2022 Jun
22;16:930697. doi: 10.3389/fncel.2022.930697. PMID: 35813504; PMCID: PMC9257210.

74: Situ M, Citalan-Madrid AF, Stamatovic SM, Keep RF, Andjelkovic AV.
Transcriptomic Profile of Blood-Brain Barrier Remodeling in Cerebral Amyloid
Angiopathy. Front Cell Neurosci. 2022 Jun 22;16:931247. doi:
10.3389/fncel.2022.931247. PMID: 35813502; PMCID: PMC9257207.

75: Li M, Wang Z, Dong S, Xu Y. NAV3 Is a Novel Prognostic Biomarker Affecting
the Immune Status of the Tumor Microenvironment in Colorectal Cancer. J Immunol
Res. 2022 Jun 30;2022:8337048. doi: 10.1155/2022/8337048. PMID: 35812247; PMCID:
PMC9262578.

76: Huang J, Li C, Shang H. Astrocytes in Neurodegeneration: Inspiration From
Genetics. Front Neurosci. 2022 Jun 24;16:882316. doi: 10.3389/fnins.2022.882316.
PMID: 35812232; PMCID: PMC9268899.

77: Pogue AI, Jaber VR, Sharfman NM, Zhao Y, Lukiw WJ. Downregulation of
Neurofilament Light Chain Expression in Human Neuronal-Glial Cell Co-Cultures by
a Microbiome-Derived Lipopolysaccharide-Induced miRNA-30b-5p. Front Neurol. 2022
Jun 24;13:900048. doi: 10.3389/fneur.2022.900048. PMID: 35812116; PMCID:
PMC9263091.

78: Zarifkar P, Peinkhofer C, Benros ME, Kondziella D. Frequency of Neurological
Diseases After COVID-19, Influenza A/B and Bacterial Pneumonia. Front Neurol.
2022 Jun 23;13:904796. doi: 10.3389/fneur.2022.904796. PMID: 35812108; PMCID:
PMC9259944.

79: Mahoney SO, Chowdhury NF, Ngo V, Imms P, Irimia A. Mild Traumatic Brain
Injury Results in Significant and Lasting Cortical Demyelination. Front Neurol.
2022 Jun 23;13:854396. doi: 10.3389/fneur.2022.854396. PMID: 35812106; PMCID:
PMC9262516.

80: Laganà V, Bruno F, Altomari N, Bruni G, Smirne N, Curcio S, Mirabelli M,
Colao R, Puccio G, Frangipane F, Cupidi C, Torchia G, Muraca G, Malvaso A,
Addesi D, Montesanto A, Di Lorenzo R, Bruni AC, Maletta R. Neuropsychiatric or
Behavioral and Psychological Symptoms of Dementia (BPSD): Focus on Prevalence
and Natural History in Alzheimer's Disease and Frontotemporal Dementia. Front
Neurol. 2022 Jun 24;13:832199. doi: 10.3389/fneur.2022.832199. PMID: 35812082;
PMCID: PMC9263122.

81: Wang A, Zhao M, Luo J, Zhang T, Zhang D. Association of Dietary Vitamin K
Intake With Cognition in the Elderly. Front Nutr. 2022 Jun 23;9:900887. doi:
10.3389/fnut.2022.900887. PMID: 35811956; PMCID: PMC9260313.

82: Zhou Y, Huang N, Li Y, Ba Z, Luo Y. Effect of icaritin on autophagy-related
protein expression in TDP-43-transfected SH-SY5Y cells. PeerJ. 2022 Jul
4;10:e13703. doi: 10.7717/peerj.13703. PMID: 35811810; PMCID: PMC9261921.

83: Zhang A, Yang Y, Xu M. Clinical Observation of Computer Vision Technology
Combined with Music Therapy in the Treatment of Alzheimer's Disease. Emerg Med
Int. 2022 Jun 29;2022:2567340. doi: 10.1155/2022/2567340. PMID: 35811609; PMCID:
PMC9259287.

84: Sun W, Wu Q, Chen H, Yu L, Yin J, Liu F, Tian R, Song B, Qu B, Xing M, Zhang
N. A Validation Study of the Hong Kong Brief Cognitive Test for Screening
Patients with Mild Cognitive Impairment and Alzheimer's Disease. J Alzheimers
Dis. 2022;88(4):1523-1532. doi: 10.3233/JAD-220417. PMID: 35811533.

85: Terracciano A, Piras MR, Sutin AR, Delitala A, Curreli NC, Balaci L,
Marongiu M, Zhu X, Aschwanden D, Luchetti M, Oppong R, Schlessinger D, Cucca F,
Launer LJ, Fiorillo E. Facets of Personality and Risk of Cognitive Impairment:
Longitudinal Findings in a Rural Community from Sardinia. J Alzheimers Dis.
2022;88(4):1651-1661. doi: 10.3233/JAD-220400. PMID: 35811532; PMCID:
PMC9398951.

86: Boujelbane MA, Trabelsi K, Boukhris O, Kacem FH, Ammar A, Charfi I, Turki M,
Charfeddine S, Bouaziz B, Hakim A, Frikha H, Chabchoub MA, Chtourou H, Glenn JM,
Myers JR. The Use of Digital Technology to Assess Cognitive Function in Tunisian
Adults. J Alzheimers Dis. 2022;88(4):1545-1552. doi: 10.3233/JAD-220398. PMID:
35811531.

87: Rahja M, Air T, Ahern S, Ward SA, Caughey GE, Sluggett JK, Cations M, Lin X,
Wallis K, Crotty M, Inacio MC. Primary and Secondary Care Related Quality
Indicators for Dementia Care Among Australian Aged Care Users: National Trends,
Risk Factors, and Variation. J Alzheimers Dis. 2022;88(4):1511-1522. doi:
10.3233/JAD-220336. PMID: 35811530.

88: Luo S, Dong X, Guo S, Wang Q, Dai X, Jiang Y, Zhu W, Zhou W, Song W.
Regulation of the Human IL-10RB Gene Expression by Sp8 and Sp9. J Alzheimers
Dis. 2022;88(4):1469-1485. doi: 10.3233/JAD-220321. PMID: 35811529.

89: Zhu MH, Jogdand AH, Jang J, Nagella SC, Das B, Milosevic MM, Yan R, Antic
SD. Evoked Cortical Depolarizations Before and After the Amyloid Plaque
Accumulation: Voltage Imaging Study. J Alzheimers Dis. 2022;88(4):1443-1458.
doi: 10.3233/JAD-220249. PMID: 35811528.

90: Li H, Su W, Dang H, Han K, Lu H, Yue S, Zhang H. Exercise Training for Mild
Cognitive Impairment Adults Older Than 60: A Systematic Review and Meta-
Analysis. J Alzheimers Dis. 2022;88(4):1263-1278. doi: 10.3233/JAD-220243. PMID:
35811527; PMCID: PMC9484098.

91: Xue C, Tang Y, Wang C, Yang H, Li L. The Effects of Normal Aging, Subjective
Cognitive Decline, Mild Cognitive Impairment, or Alzheimer's Disease on Visual
Search. J Alzheimers Dis. 2022;88(4):1639-1650. doi: 10.3233/JAD-220209. PMID:
35811526.

92: Bleakley A, Maloney EK, Harkins K, Nelson MN, Akpek E, Langbaum JB. An
Elicitation Study to Understand Black, Hispanic, and Male Older Adults'
Willingness to Participate in Alzheimer's Disease-Focused Research Registries. J
Alzheimers Dis. 2022;88(4):1499-1509. doi: 10.3233/JAD-220196. PMID: 35811525.

93: Ramanan VK, Heckman MG, Przybelski SA, Lesnick TG, Lowe VJ, Graff-Radford J,
Mielke M, Jack CR, Knopman DS, Petersen RC, Ross OA, Vemuri P; Alzheimer’s
Disease Neuroimaging Initiative. Polygenic Scores of Alzheimer's Disease Risk
Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden. J
Alzheimers Dis. 2022;88(4):1615-1625. doi: 10.3233/JAD-220164. PMID: 35811524.

94: Camino J, Khondoker M, Trucco AP, Backhouse T, Kishita N, Mioshi E.
Contributions of Caregiver Management Styles to the Discrepancy Between Reported
and Observed Task Performance in People with Dementia. J Alzheimers Dis.
2022;88(4):1605-1614. doi: 10.3233/JAD-220155. PMID: 35811523.

95: Nabirotchkin S, Bouaziz J, Glibert F, Mandel J, Foucquier J, Hajj R,
Callizot N, Cholet N, Guedj M, Cohen D. Combinational Drug Repurposing from
Genetic Networks Applied to Alzheimer's Disease. J Alzheimers Dis.
2022;88(4):1585-1603. doi: 10.3233/JAD-220120. PMID: 35811522.

96: Chia SY, Vipin A, Ng KP, Tu H, Bommakanti A, Wang BZ, Tan YJ, Zailan FZ, Ng
ASL, Ling SC, Okamura K, Tan EK, Kandiah N, Zeng L. Upregulated Blood miR-150-5p
in Alzheimer's Disease Dementia Is Associated with Cognition, Cerebrospinal
Fluid Amyloid-β, and Cerebral Atrophy. J Alzheimers Dis. 2022;88(4):1567-1584.
doi: 10.3233/JAD-220116. PMID: 35811521.

97: Zhang X, Cong R, Geng T, Zhang J, Liu D, Tian Q, Meng X, Song M, Wu L, Zheng
D, Wang W, Wang B, Wang Y. Assessment of the Causal Effect of IgG
N-Glycosylation Level on Risk of Dementia: A 2-Sample Mendelian Randomization
Study. J Alzheimers Dis. 2022;88(4):1435-1441. doi: 10.3233/JAD-220074. PMID:
35811520.

98: Tsujimoto M, Suzuki K, Saji N, Sakurai T, Ito K, Toba K; Registry Study
Group ORANGE. Organized Registration for the Assessment of Dementia by the
Nationwide General Consortium Toward Effective Treatment (ORANGE) Registry:
Current Status and Perspectives of Mild Cognitive Impairment. J Alzheimers Dis.
2022;88(4):1423-1433. doi: 10.3233/JAD-220039. PMID: 35811519.

99: Toups K, Hathaway A, Gordon D, Chung H, Raji C, Boyd A, Hill BD, Hausman-
Cohen S, Attarha M, Chwa WJ, Jarrett M, Bredesen DE. Precision Medicine Approach
to Alzheimer's Disease: Successful Pilot Project. J Alzheimers Dis.
2022;88(4):1411-1421. doi: 10.3233/JAD-215707. PMID: 35811518; PMCID:
PMC9484109.

100: Krishnadas N, Huang K, Schultz SA, Doré V, Bourgeat P, Goh AMY, Lamb F,
Bozinovski S, Burnham SC, Robertson JS, Laws SM, Maruff P, Masters CL,
Villemagne VL, Rowe CC. Visually Identified Tau 18F-MK6240 PET Patterns in
Symptomatic Alzheimer's Disease. J Alzheimers Dis. 2022;88(4):1627-1637. doi:
10.3233/JAD-215558. PMID: 35811517; PMCID: PMC9484111.

101: Polcher A, Wolfsgruber S, Peters O, Frölich L, Wiltfang J, Kornhuber J,
Hüll M, Rüther E, Lewczuk P, Maier W, Jessen F, Wagner M. A Comparison of
Operational Definitions for Mild Cognitive Impairment. J Alzheimers Dis.
2022;88(4):1663-1678. doi: 10.3233/JAD-215548. PMID: 35811516; PMCID:
PMC9484125.

102: Howard E, Ballinger S, Kinney NG, Balgenorth Y, Ehrhardt A, Phillips JS,
Irwin DJ, Grossman M, Cousins KAQ. Frontal Atrophy and Executive Dysfunction
Relate to Complex Numbers Impairment in Progressive Supranuclear Palsy. J
Alzheimers Dis. 2022;88(4):1553-1566. doi: 10.3233/JAD-215327. PMID: 35811515.

103: Papaioannou T, Voinescu A, Petrini K, Stanton Fraser D. Efficacy and
Moderators of Virtual Reality for Cognitive Training in People with Dementia and
Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. J Alzheimers
Dis. 2022;88(4):1341-1370. doi: 10.3233/JAD-210672. PMID: 35811514.

104: Eikelboom WS, Lazaar N, van Bruchem-Visser RL, Mattace-Raso FUS, Coesmans
M, Ossenkoppele R, van den Berg E, Papma JM. The recognition and management of
neuropsychiatric symptoms in early Alzheimer's disease: a qualitative study
among Dutch memory clinic physicians. Psychogeriatrics. 2022 Sep;22(5):707-717.
doi: 10.1111/psyg.12874. Epub 2022 Jul 10. PMID: 35811380.

105: Padda IS, Parmar M. Aducanumab. 2022 Jul 12. In: StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 34424635.

106: Bonfili L, Cuccioloni M, Gong C, Cecarini V, Spina M, Zheng Y, Angeletti M,
Eleuteri AM. Reply - Letter to the editor "Comment on "Gut microbiota modulation
in Alzheimer's disease: Focus on lipid metabolism Clinical nutrition 2022". Clin
Nutr. 2022 Jun 30:S0261-5614(22)00223-0. doi: 10.1016/j.clnu.2022.06.029. Epub
ahead of print. PMID: 35811234.

107: Fenton L, Weissberger GH, Boyle PA, Mosqueda L, Yassine HN, Nguyen AL, Lim
AC, Han SD. Cognitive and neuroimaging correlates of financial exploitation
vulnerability in older adults without dementia: Implications for early detection
of Alzheimer's disease. Neurosci Biobehav Rev. 2022 Sep;140:104773. doi:
10.1016/j.neubiorev.2022.104773. Epub 2022 Jul 8. PMID: 35811006.

108: Zhang Y, Liu D, Yao X, Wen J, Wang Y, Zhang Y. DMTHB ameliorates memory
impairment in Alzheimer's disease mice through regulation of neuroinflammation.
Neurosci Lett. 2022 Aug 10;785:136770. doi: 10.1016/j.neulet.2022.136770. Epub
2022 Jul 8. PMID: 35810961.

109: Reagin KL, Funk KE. The role of antiviral CD8<sup>+</sup> T cells in
cognitive impairment. Curr Opin Neurobiol. 2022 Oct;76:102603. doi:
10.1016/j.conb.2022.102603. Epub 2022 Jul 8. PMID: 35810534; PMCID: PMC9489663.

110: Yu Y, Yang M, Zhuang X, Pan J, Zhao Y, Yu Y. Effects of toxic
apolipoprotein E fragments on Tau phosphorylation and cognitive impairment in
neonatal mice under sevoflurane anesthesia. Brain Behav. 2022 Aug;12(8):e2702.
doi: 10.1002/brb3.2702. Epub 2022 Jul 10. PMID: 35810473; PMCID: PMC9392520.

111: Domenighetti C, Douillard V, Sugier PE, Sreelatha AAK, Schulte C, Grover S,
May P, Bobbili DR, Radivojkov-Blagojevic M, Lichtner P, Singleton AB, Hernandez
DG, Edsall C, Gourraud PA, Mellick GD, Zimprich A, Pirker W, Rogaeva E, Lang AE,
Koks S, Taba P, Lesage S, Brice A, Corvol JC, Chartier-Harlin MC, Mutez E,
Brockmann K, Deutschländer AB, Hadjigeorgiou GM, Dardiotis E, Stefanis L,
Simitsi AM, Valente EM, Petrucci S, Duga S, Straniero L, Zecchinelli A, Pezzoli
G, Brighina L, Ferrarese C, Annesi G, Quattrone A, Gagliardi M, Matsuo H,
Nakayama A, Hattori N, Nishioka K, Chung SJ, Kim YJ, Kolber P, van de Warrenburg
BPC, Bloem BR, Aasly J, Toft M, Pihlstrøm L, Correia Guedes L, Ferreira JJ,
Bardien S, Carr J, Tolosa E, Ezquerra M, Pastor P, Diez-Fairen M, Wirdefeldt K,
Pedersen NL, Ran C, Belin AC, Puschmann A, Ygland Rödström E, Clarke CE,
Morrison KE, Tan M, Krainc D, Burbulla LF, Farrer MJ, Krüger R, Gasser T, Sharma
M, Vince N, Elbaz A; Comprehensive Unbiased Risk Factor Assessment for Genetics
and Environment in Parkinson's Disease (Courage-PD) Consortium. The Interaction
between HLA-DRB1 and Smoking in Parkinson's Disease Revisited. Mov Disord. 2022
Sep;37(9):1929-1937. doi: 10.1002/mds.29133. Epub 2022 Jul 10. PMID: 35810454.

112: Reho P, Koga S, Shah Z, Chia R; International LBD Genomics Consortium;
American Genome Center, Rademakers R, Dalgard CL, Boeve BF, Beach TG, Dickson
DW, Ross OA, Scholz SW. GRN Mutations Are Associated with Lewy Body Dementia.
Mov Disord. 2022 Sep;37(9):1943-1948. doi: 10.1002/mds.29144. Epub 2022 Jul 10.
PMID: 35810449; PMCID: PMC9474656.

113: Kuns B, Rosani A, Varghese D. Memantine. 2022 Jul 11. In: StatPearls
[Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID:
29763201.

114: Companys-Alemany J, Turcu AL, Schneider M, Müller CE, Vázquez S, Griñán-
Ferré C, Pallàs M. NMDA receptor antagonists reduce amyloid-β deposition by
modulating calpain-1 signaling and autophagy, rescuing cognitive impairment in
5XFAD mice. Cell Mol Life Sci. 2022 Jul 9;79(8):408. doi:
10.1007/s00018-022-04438-4. PMID: 35810220; PMCID: PMC9271115.

115: Khojaste-Sarakhsi M, Haghighi SS, Ghomi SMTF, Marchiori E. Deep learning
for Alzheimer's disease diagnosis: A survey. Artif Intell Med. 2022
Aug;130:102332. doi: 10.1016/j.artmed.2022.102332. Epub 2022 Jun 12. PMID:
35809971.

116: Wickramasuriya N, Hawkins R, Atwood C, Butler T. The roles of GnRH in the
human central nervous system. Horm Behav. 2022 Jul 6;145:105230. doi:
10.1016/j.yhbeh.2022.105230. Epub ahead of print. PMID: 35809386.

117: Calcetas AT, Thomas KR, Edmonds EC, Holmqvist SL, Edwards L, Bordyug M,
Delano-Wood L, Brickman AM, Bondi MW, Bangen KJ, For The Alzheimer's Disease
Neuroimaging Initiative. Increased regional white matter hyperintensity volume
in objectively-defined subtle cognitive decline and mild cognitive impairment.
Neurobiol Aging. 2022 Oct;118:1-8. doi: 10.1016/j.neurobiolaging.2022.06.002.
Epub 2022 Jun 16. PMID: 35809348.

118: Homma T, Fujiwara H, Osaki T, Fujii S, Fujii J. Consequences of a
peroxiredoxin 4 (Prdx4) deficiency on learning and memory in mice. Biochem
Biophys Res Commun. 2022 Sep 17;621:32-38. doi: 10.1016/j.bbrc.2022.06.096. Epub
2022 Jul 3. PMID: 35809345.

119: Ahmad SS, Khan H, Khalid M, Almalki AS. Emetine and Indirubin- 3- monoxime
interaction with human brain acetylcholinesterase: A computational and
statistical analysis. Cell Mol Biol (Noisy-le-grand). 2022 Jan 2;67(4):106-114.
doi: 10.14715/cmb/2021.67.4.12. PMID: 35809297.

120: Nazarian A, Philipp I, Culminskaya I, He L, Kulminski AM. Inter- and intra-
chromosomal modulators of the APOE ɛ2 and ɛ4 effects on the Alzheimer's disease
risk. Geroscience. 2022 Jul 9. doi: 10.1007/s11357-022-00617-0. Epub ahead of
print. PMID: 35809216.

121: Saha S, Khan N, Comi T, Verhagen A, Sasmal A, Diaz S, Yu H, Chen X, Akey
JM, Frank M, Gagneux P, Varki A. Evolution of Human-Specific Alleles Protecting
Cognitive Function of Grandmothers. Mol Biol Evol. 2022 Aug 3;39(8):msac151.
doi: 10.1093/molbev/msac151. PMID: 35809046; PMCID: PMC9356730.

122: Arnold MR, Coughlin DG, Brumbach BH, Smirnov DS, Concha-Marambio L, Farris
CM, Ma Y, Kim Y, Wilson EN, Kaye JA, Hiniker A, Woltjer RL, Galasko DR, Quinn
JF. α-Synuclein Seed Amplification in CSF and Brain from Patients with Different
Brain Distributions of Pathological α-Synuclein in the Context of Co-Pathology
and Non-LBD Diagnoses. Ann Neurol. 2022 Oct;92(4):650-662. doi:
10.1002/ana.26453. Epub 2022 Jul 29. PMID: 35808984; PMCID: PMC9489647.

123: Waris A, Ali A, Khan AU, Asim M, Zamel D, Fatima K, Raziq A, Khan MA, Akbar
N, Baset A, Abourehab MAS. Applications of Various Types of Nanomaterials for
the Treatment of Neurological Disorders. Nanomaterials (Basel). 2022 Jun
22;12(13):2140. doi: 10.3390/nano12132140. PMID: 35807977; PMCID: PMC9268720.

124: Vu THT, Beck T, Bennett DA, Schneider JA, Hayden KM, Shadyab AH, Rajan KB,
Morris MC, Cornelis MC. Adherence to MIND Diet, Genetic Susceptibility, and
Incident Dementia in Three US Cohorts. Nutrients. 2022 Jul 3;14(13):2759. doi:
10.3390/nu14132759. PMID: 35807939; PMCID: PMC9268772.

125: Eicher TP, Mohajeri MH. Overlapping Mechanisms of Action of Brain-Active
Bacteria and Bacterial Metabolites in the Pathogenesis of Common Brain Diseases.
Nutrients. 2022 Jun 27;14(13):2661. doi: 10.3390/nu14132661. PMID: 35807841;
PMCID: PMC9267981.

126: Purgatorio R, Gambacorta N, Samarelli F, Lopopolo G, de Candia M, Catto M,
Nicolotti O, Altomare CD. Assessing the Role of a Malonamide Linker in the
Design of Potent Dual Inhibitors of Factor Xa and Cholinesterases. Molecules.
2022 Jul 2;27(13):4269. doi: 10.3390/molecules27134269. PMID: 35807514; PMCID:
PMC9268553.

127: Kruk-Slomka M, Dzik A, Biala G. The Influence of CB2-Receptor Ligands on
the Memory-Related Responses in Connection with Cholinergic Pathways in Mice in
the Passive Avoidance Test. Molecules. 2022 Jul 1;27(13):4252. doi:
10.3390/molecules27134252. PMID: 35807499; PMCID: PMC9268103.

128: Wang S, Kong X, Chen Z, Wang G, Zhang J, Wang J. Role of Natural Compounds
and Target Enzymes in the Treatment of Alzheimer's Disease. Molecules. 2022 Jun
29;27(13):4175. doi: 10.3390/molecules27134175. PMID: 35807418; PMCID:
PMC9268689.

129: Zhu Z, Zhao S, Wang C. Antibacterial, Antifungal, Antiviral, and
Antiparasitic Activities of <i>Peganum harmala</i> and Its Ingredients: A
Review. Molecules. 2022 Jun 29;27(13):4161. doi: 10.3390/molecules27134161.
PMID: 35807407; PMCID: PMC9268262.

130: Han Y, Chen L, Liu J, Chen J, Wang C, Guo Y, Yu X, Zhang C, Chu H, Ma H. A
Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-
Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway. Molecules.
2022 Jun 29;27(13):4160. doi: 10.3390/molecules27134160. PMID: 35807406; PMCID:
PMC9268711.

131: Althafar ZM. Targeting Microglia in Alzheimer's Disease: From Molecular
Mechanisms to Potential Therapeutic Targets for Small Molecules. Molecules. 2022
Jun 27;27(13):4124. doi: 10.3390/molecules27134124. PMID: 35807370; PMCID:
PMC9268715.

132: Navarro-Martos R, Nieto-Escamez F. A Proposal of Cognitive Intervention in
Patients with Alzheimer's Disease through an Assembling Game: A Pilot Study. J
Clin Med. 2022 Jul 5;11(13):3907. doi: 10.3390/jcm11133907. PMID: 35807192;
PMCID: PMC9267896.

133: Szandruk-Bender M, Wiatrak B, Szeląg A. The Risk of Developing Alzheimer's
Disease and Parkinson's Disease in Patients with Inflammatory Bowel Disease: A
Meta-Analysis. J Clin Med. 2022 Jun 27;11(13):3704. doi: 10.3390/jcm11133704.
PMID: 35806985; PMCID: PMC9267426.

134: Lin YK, Liang CS, Tsai CK, Tsai CL, Lee JT, Sung YF, Chou CH, Shang HS,
Yang BH, Lin GY, Su MW, Yang FC. A Metallomic Approach to Assess Associations of
Plasma Metal Levels with Amnestic Mild Cognitive Impairment and Alzheimer's
Disease: An Exploratory Study. J Clin Med. 2022 Jun 24;11(13):3655. doi:
10.3390/jcm11133655. PMID: 35806940; PMCID: PMC9267221.

135: Rao AC, Venkatesh KV, Nandini V, Sihivahanan D, Alamoudi A, Bahammam HA,
Bahammam SA, Zidane B, Bahammam MA, Chohan H, Albar NH, Yadalam PK, Patil S.
Evaluating the Effect of Tideglusib-Loaded Bioactive Glass Nanoparticles as a
Potential Dentine Regenerative Material. Materials (Basel). 2022 Jun
29;15(13):4567. doi: 10.3390/ma15134567. PMID: 35806692; PMCID: PMC9267687.

136: Muqaku B, Oeckl P. Peptidomic Approaches and Observations in
Neurodegenerative Diseases. Int J Mol Sci. 2022 Jun 30;23(13):7332. doi:
10.3390/ijms23137332. PMID: 35806335; PMCID: PMC9266836.

137: Mota BC, Ashburner N, Abelleira-Hervas L, Liu L, Aleksynas R, Rovati LC,
Caselli G, Sastre M. I2-Imidazoline Ligand CR4056 Improves Memory, Increases
ApoE Expression and Reduces BBB Leakage in 5xFAD Mice. Int J Mol Sci. 2022 Jun
30;23(13):7320. doi: 10.3390/ijms23137320. PMID: 35806327; PMCID: PMC9266435.

138: Holper S, Watson R, Yassi N. Tau as a Biomarker of Neurodegeneration. Int J
Mol Sci. 2022 Jun 30;23(13):7307. doi: 10.3390/ijms23137307. PMID: 35806324;
PMCID: PMC9266883.

139: Ahmed S, Jing Y, Mockett BG, Zhang H, Abraham WC, Liu P. Partial
Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and
Amyloid Pathology in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease. Int J
Mol Sci. 2022 Jun 30;23(13):7316. doi: 10.3390/ijms23137316. PMID: 35806318;
PMCID: PMC9266765.

140: Leyane TS, Jere SW, Houreld NN. Oxidative Stress in Ageing and Chronic
Degenerative Pathologies: Molecular Mechanisms Involved in Counteracting
Oxidative Stress and Chronic Inflammation. Int J Mol Sci. 2022 Jun
30;23(13):7273. doi: 10.3390/ijms23137273. PMID: 35806275; PMCID: PMC9266760.

141: Das S, Dewit N, Jacobs D, Pijnenburg YAL, In 't Veld SGJG, Coppens S,
Quaglia M, Hirtz C, Teunissen CE, Vanmechelen E. A Novel Neurofilament Light
Chain ELISA Validated in Patients with Alzheimer's Disease, Frontotemporal
Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate
Proteins for Immunoassay Calibration. Int J Mol Sci. 2022 Jun 29;23(13):7221.
doi: 10.3390/ijms23137221. PMID: 35806226; PMCID: PMC9266977.

142: Tucci S. An Altered Sphingolipid Profile as a Risk Factor for Progressive
Neurodegeneration in Long-Chain 3-Hydroxyacyl-CoA Deficiency (LCHADD). Int J Mol
Sci. 2022 Jun 27;23(13):7144. doi: 10.3390/ijms23137144. PMID: 35806149; PMCID:
PMC9266703.

143: McCorkindale AN, Mundell HD, Guennewig B, Sutherland GT. Vascular
Dysfunction Is Central to Alzheimer's Disease Pathogenesis in APOE e4 Carriers.
Int J Mol Sci. 2022 Jun 26;23(13):7106. doi: 10.3390/ijms23137106. PMID:
35806110; PMCID: PMC9266739.

144: Milanowski LM, Hou X, Bredenberg JM, Fiesel FC, Cocker LT, Soto-Beasley AI,
Walton RL, Strongosky AJ, Faroqi AH, Barcikowska M, Boczarska-Jedynak M, Dulski
J, Fedoryshyn L, Janik P, Potulska-Chromik A, Karpinsky K, Krygowska-Wajs A,
Lynch T, Olszewska DA, Opala G, Pulyk A, Rektorova I, Sanotsky Y, Siuda J,
Widlak M, Slawek J, Rudzinska-Bar M, Uitti R, Figura M, Szlufik S, Rzonca-
Niewczas S, Podgorska E, McLean PJ, Koziorowski D, Ross OA, Hoffman-Zacharska D,
Springer W, Wszolek ZK. Cathepsin B p.Gly284Val Variant in Parkinson's Disease
Pathogenesis. Int J Mol Sci. 2022 Jun 25;23(13):7086. doi: 10.3390/ijms23137086.
PMID: 35806091; PMCID: PMC9266886.

145: Burlando B, Losacco S, Villa V, Fedele E, Ricciarelli R. A New Bistable
Switch Model of Alzheimer's Disease Pathogenesis. Int J Mol Sci. 2022 Jun
25;23(13):7061. doi: 10.3390/ijms23137061. PMID: 35806088; PMCID: PMC9267076.

146: Jehle A, Garaschuk O. The Interplay between cGMP and Calcium Signaling in
Alzheimer's Disease. Int J Mol Sci. 2022 Jun 24;23(13):7048. doi:
10.3390/ijms23137048. PMID: 35806059; PMCID: PMC9266933.

147: Choi YK, Kim YM. Beneficial and Detrimental Roles of Heme Oxygenase-1 in
the Neurovascular System. Int J Mol Sci. 2022 Jun 24;23(13):7041. doi:
10.3390/ijms23137041. PMID: 35806040; PMCID: PMC9266949.

148: Blagov AV, Grechko AV, Nikiforov NG, Borisov EE, Sadykhov NK, Orekhov AN.
Role of Impaired Mitochondrial Dynamics Processes in the Pathogenesis of
Alzheimer's Disease. Int J Mol Sci. 2022 Jun 23;23(13):6954. doi:
10.3390/ijms23136954. PMID: 35805958; PMCID: PMC9266759.

149: Tedeschi P, Nigro M, Travagli A, Catani M, Cavazzini A, Merighi S, Gessi S.
Therapeutic Potential of Allicin and Aged Garlic Extract in Alzheimer's Disease.
Int J Mol Sci. 2022 Jun 22;23(13):6950. doi: 10.3390/ijms23136950. PMID:
35805955; PMCID: PMC9266652.

150: Barba L, Halbgebauer S, Paolini Paoletti F, Bellomo G, Abu-Rumeileh S,
Steinacker P, Massa F, Parnetti L, Otto M. Specific Cerebrospinal Fluid SerpinA1
Isoform Pattern in Alzheimer's Disease. Int J Mol Sci. 2022 Jun 22;23(13):6922.
doi: 10.3390/ijms23136922. PMID: 35805926; PMCID: PMC9266332.

151: Orellana A, García-González P, Valero S, Montrreal L, de Rojas I, Hernández
I, Rosende-Roca M, Vargas L, Tartari JP, Esteban-De Antonio E, Bojaryn U,
Narvaiza L, Alarcón-Martín E, Alegret M, Alcolea D, Lleó A, Tárraga L, Pytel V,
Cano A, Marquié M, Boada M, Ruiz A. Establishing In-House Cutoffs of CSF
Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer
Center Barcelona Cohort. Int J Mol Sci. 2022 Jun 21;23(13):6891. doi:
10.3390/ijms23136891. PMID: 35805894; PMCID: PMC9266894.

152: Hui Z, Wang X, Zhou Y, Li Y, Ren X, Wang M. Global Research on Cognitive
Frailty: A Bibliometric and Visual Analysis of Papers Published during
2013-2021. Int J Environ Res Public Health. 2022 Jul 4;19(13):8170. doi:
10.3390/ijerph19138170. PMID: 35805829; PMCID: PMC9265998.

153: Kim J, Lee J, Kim YS, Park SH. Identifying the Relationship between Leisure
Walking and Prevalence of Alzheimer's Disease and Other Dementias. Int J Environ
Res Public Health. 2022 Jun 30;19(13):8076. doi: 10.3390/ijerph19138076. PMID:
35805735; PMCID: PMC9265613.

154: Jung G, Lee J. Behavioral and Psychological Symptoms and Associated Factors
in Community-Dwelling Persons at the First Time of Dementia Diagnosis. Int J
Environ Res Public Health. 2022 Jun 24;19(13):7765. doi: 10.3390/ijerph19137765.
PMID: 35805421; PMCID: PMC9265813.

155: Wendimu MY, Hooks SB. Microglia Phenotypes in Aging and Neurodegenerative
Diseases. Cells. 2022 Jun 30;11(13):2091. doi: 10.3390/cells11132091. PMID:
35805174; PMCID: PMC9266143.

156: Zoungrana LI, Krause-Hauch M, Wang H, Fatmi MK, Bates L, Li Z, Kulkarni P,
Ren D, Li J. The Interaction of <i>mTOR</i> and <i>Nrf2</i> in Neurogenesis and
Its Implication in Neurodegenerative Diseases. Cells. 2022 Jun 28;11(13):2048.
doi: 10.3390/cells11132048. PMID: 35805130; PMCID: PMC9265429.

157: McGinnis CD, Jennings EQ, Harris PS, Galligan JJ, Fritz KS. Biochemical
Mechanisms of Sirtuin-Directed Protein Acylation in Hepatic Pathologies of
Mitochondrial Dysfunction. Cells. 2022 Jun 28;11(13):2045. doi:
10.3390/cells11132045. PMID: 35805129; PMCID: PMC9266223.

158: Monti G, Gomes Moreira D, Richner M, Mutsaers HAM, Ferreira N, Jan A. GLP-1
Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight.
Cells. 2022 Jun 25;11(13):2023. doi: 10.3390/cells11132023. PMID: 35805109;
PMCID: PMC9265397.

159: Spurgat MS, Tang SJ. Single-Cell RNA-Sequencing: Astrocyte and Microglial
Heterogeneity in Health and Disease. Cells. 2022 Jun 24;11(13):2021. doi:
10.3390/cells11132021. PMID: 35805105; PMCID: PMC9265979.

160: Dave A, Park EJ, Kumar A, Parande F, Beyoğlu D, Idle JR, Pezzuto JM.
Consumption of Grapes Modulates Gene Expression, Reduces Non-Alcoholic Fatty
Liver Disease, and Extends Longevity in Female C57BL/6J Mice Provided with a
High-Fat Western-Pattern Diet. Foods. 2022 Jul 5;11(13):1984. doi:
10.3390/foods11131984. PMID: 35804799; PMCID: PMC9265568.

161: Liu Y, Ren X, Fan C, Wu W, Zhang W, Wang Y. Health Benefits, Food
Applications, and Sustainability of Microalgae-Derived N-3 PUFA. Foods. 2022 Jun
25;11(13):1883. doi: 10.3390/foods11131883. PMID: 35804698; PMCID: PMC9265382.

162: Kang BW, Kim F, Cho JY, Kim S, Rhee J, Choung JJ. Phosphodiesterase 5
inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by
multimodal actions. Alzheimers Res Ther. 2022 Jul 8;14(1):92. doi:
10.1186/s13195-022-01034-3. PMID: 35804462; PMCID: PMC9264543.

163: Mai M, Guo X, Huang Y, Zhang W, Xu Y, Zhang Y, Bai X, Wu J, Zu H. DHCR24
Knockdown Induces Tau Hyperphosphorylation at Thr181, Ser199, Ser262, and Ser396
Sites via Activation of the Lipid Raft-Dependent Ras/MEK/ERK Signaling Pathway
in C8D1A Astrocytes. Mol Neurobiol. 2022 Sep;59(9):5856-5873. doi:
10.1007/s12035-022-02945-w. Epub 2022 Jul 8. PMID: 35804281; PMCID: PMC9395500.

164: Gerstenecker A, Norling AM, Jacob A, Lazar RM. Silent Brain Infarction,
Delirium, and Cognition in Three Invasive Cardiovascular Procedures: a
Systematic Review. Neuropsychol Rev. 2022 Jul 8. doi:
10.1007/s11065-022-09548-1. Epub ahead of print. PMID: 35804216.

165: Hlávka JP, Tysinger B, Yu JC, Lakdawalla DN. Access to Disease-Modifying
Alzheimer's Therapies: Addressing Possible Challenges Using Innovative Payment
Models. Value Health. 2022 Jul 5:S1098-3015(22)02039-3. doi:
10.1016/j.jval.2022.06.003. Epub ahead of print. PMID: 35803845.

166: Behera A, Sharma O, Paul D, Sain A. Temperature-dependent self-assembly of
biofilaments during red blood cell sickling. J Chem Phys. 2022 Jul
7;157(1):014105. doi: 10.1063/5.0091690. PMID: 35803791.

167: Fernandez Bessone I, Navarro J, Martinez E, Karmirian K, Holubiec M,
Alloatti M, Goto-Silva L, Arnaiz Yepez C, Martins-de-Souza D, Nascimento JM,
Bruno L, Saez TM, Rehen SK, Falzone TL. DYRK1A regulates the bidirectional
axonal transport of APP in human-derived neurons. J Neurosci. 2022 Jul
8;42(33):6344–58. doi: 10.1523/JNEUROSCI.2551-21.2022. Epub ahead of print.
PMID: 35803734; PMCID: PMC9398544.

168: Perdomo VA, Ortega DC, Barreto G. Polymorphisms of apolipoprotein E in the
Afro-descendant population of Buenaventura, Colombia. Rev Colomb Psiquiatr (Engl
Ed). 2022 Apr-Jun;51(2):99-104. English, Spanish. doi:
10.1016/j.rcpeng.2020.10.005. PMID: 35803688.

169: Hendricksen M, Mitchell SL, Palan Lopez R, Roach A, Rogers AH, Akunor H,
McCarthy EP. ADVANCE-C: A Qualitative Study of Experiences Caring for Nursing
Home Residents with Advanced Dementia during the COVID-19 Pandemic. J Gerontol B
Psychol Sci Soc Sci. 2022 Jul 8:gbac093. doi: 10.1093/geronb/gbac093. Epub ahead
of print. PMID: 35803591; PMCID: PMC9278215.

170: Jin M, Xu R, Wang L, Alam MM, Ma Z, Zhu S, Martini AC, Jadali A, Bernabucci
M, Xie P, Kwan KY, Pang ZP, Head E, Liu Y, Hart RP, Jiang P. Type-I-interferon
signaling drives microglial dysfunction and senescence in human iPSC models of
Down syndrome and Alzheimer's disease. Cell Stem Cell. 2022 Jul
7;29(7):1135-1153.e8. doi: 10.1016/j.stem.2022.06.007. PMID: 35803230; PMCID:
PMC9345168.

171: Naseri A, Baghernezhad K, Seyedi-Sahebari S, Alhoseini SA, Gholipour-
Khalili E, Zafarani F, Talebi M. The association of apolipoprotein E (ApoE)
genotype and cognitive outcomes in multiple sclerosis; a systematic review and
meta-analysis. Mult Scler Relat Disord. 2022 Sep;65:104011. doi:
10.1016/j.msard.2022.104011. Epub 2022 Jul 3. PMID: 35803087.

172: Mankowski RT, Justice JN. Translational research on aging and adaptations
to exercise. Exp Gerontol. 2022 Sep;166:111872. doi:
10.1016/j.exger.2022.111872. Epub 2022 Jun 24. PMID: 35803083.

173: Mondino A, Gutiérrez M, González C, Mateos D, Torterolo P, Olby N, Delucchi
L. Electroencephalographic signatures of dogs with presumptive diagnosis of
canine cognitive dysfunction. Res Vet Sci. 2022 Dec 5;150:36-43. doi:
10.1016/j.rvsc.2022.06.024. Epub 2022 Jul 2. PMID: 35803005.

174: Miller JE, Srinivasan Y, Dharmaraj NP, Liu A, Nguyen PL, Taylor SD, Yeates
TO. Designing Protease-Triggered Protein Cages. J Am Chem Soc. 2022 Jul
20;144(28):12681-12689. doi: 10.1021/jacs.2c02165. Epub 2022 Jul 8. PMID:
35802879.

175: Morsy A, Maddeboina K, Gao J, Wang H, Valdez J, Dow LF, Wang X, Trippier
PC. Functionalized Allopurinols Targeting Amyloid-Binding Alcohol Dehydrogenase
Rescue Aβ-Induced Mitochondrial Dysfunction. ACS Chem Neurosci. 2022 Jul
20;13(14):2176-2190. doi: 10.1021/acschemneuro.2c00246. Epub 2022 Jul 8. PMID:
35802826.

176: Ali SK, Ali RH. Effects of antidiabetic agents on Alzheimer's disease
biomarkers in experimentally induced hyperglycemic rat model by streptozocin.
PLoS One. 2022 Jul 8;17(7):e0271138. doi: 10.1371/journal.pone.0271138. PMID:
35802659; PMCID: PMC9269384.

177: Vidoni ED, Morris JK, Palmer JA, Li Y, White D, Kueck PJ, John CS, Honea
RA, Lepping RJ, Lee P, Mahnken JD, Martin LE, Billinger SA. Dementia risk and
dynamic response to exercise: A non-randomized clinical trial. PLoS One. 2022
Jul 8;17(7):e0265860. doi: 10.1371/journal.pone.0265860. PMID: 35802628; PMCID:
PMC9269742.

178: Khezri MR, Ghasemnejad-Berenji M. Icariin: A Potential Neuroprotective
Agent in Alzheimer's Disease and Parkinson's Disease. Neurochem Res. 2022
Oct;47(10):2954-2962. doi: 10.1007/s11064-022-03667-0. Epub 2022 Jul 8. PMID:
35802286.

179: Lee YC, Sousa TV, Stretton-Smith PA, Gold C, Geretsegger M, Baker FA.
Demographic and clinical profile of residents living with dementia and
depressive symptoms in Australian private residential aged care: Data from the
Music Interventions for Dementia and Depression in ELderly care (MIDDEL)
cluster-randomised controlled trial. Australas J Ageing. 2022 Jul 8. doi:
10.1111/ajag.13104. Epub ahead of print. PMID: 35801957.

180: Ji YM, Zhang W, Zhang JD, Li XF, Yu FD, Li CY, Liu GJ, Xing GW. Dual
functional amphiphilic sugar-coated AIE-active fluorescent organic nanoparticles
for the monitoring and inhibition of insulin amyloid fibrillation based on
carbohydrate-protein interactions. J Mater Chem B. 2022 Jul 27;10(29):5602-5611.
doi: 10.1039/d2tb01070d. PMID: 35801534.

181: Vijayan M, Alvir RV, Alvir RV, Bunquin LE, Pradeepkiran JA, Reddy PH. A
partial reduction of VDAC1 enhances mitophagy, autophagy, synaptic activities in
a transgenic Tau mouse model. Aging Cell. 2022 Aug;21(8):e13663. doi:
10.1111/acel.13663. Epub 2022 Jul 7. PMID: 35801276; PMCID: PMC9381918.

182: Liu C. The Role of Mesenchymal Stem Cells in Regulating Astrocytes-Related
Synapse Dysfunction in Early Alzheimer's Disease. Front Neurosci. 2022 Jun
21;16:927256. doi: 10.3389/fnins.2022.927256. PMID: 35801178; PMCID: PMC9253587.

183: Vrijsen S, Vrancx C, Del Vecchio M, Swinnen JV, Agostinis P, Winderickx J,
Vangheluwe P, Annaert W. Inter-organellar Communication in Parkinson's and
Alzheimer's Disease: Looking Beyond Endoplasmic Reticulum-Mitochondria Contact
Sites. Front Neurosci. 2022 Jun 21;16:900338. doi: 10.3389/fnins.2022.900338.
PMID: 35801175; PMCID: PMC9253489.

184: Sheng J, Liu J, Chan KHK. Evaluating the Causal Effects of Gestational
Diabetes Mellitus, Heart Disease, and High Body Mass Index on Maternal
Alzheimer's Disease and Dementia: Multivariable Mendelian Randomization. Front
Genet. 2022 Jun 21;13:833734. doi: 10.3389/fgene.2022.833734. PMID: 35801085;
PMCID: PMC9255379.

185: Badji A, Cohen-Adad J, Girouard H. Relationship Between Arterial Stiffness
Index, Pulse Pressure, and Magnetic Resonance Imaging Markers of White Matter
Integrity: A UK Biobank Study. Front Aging Neurosci. 2022 Jun 21;14:856782. doi:
10.3389/fnagi.2022.856782. PMID: 35800980; PMCID: PMC9252854.

186: Ávila-Villanueva M, Marcos Dolado A, Gómez-Ramírez J, Fernández-Blázquez M.
Brain Structural and Functional Changes in Cognitive Impairment Due to
Alzheimer's Disease. Front Psychol. 2022 Jun 21;13:886619. doi:
10.3389/fpsyg.2022.886619. PMID: 35800946; PMCID: PMC9253821.

187: Kivisäkk P, Magdamo C, Trombetta BA, Noori A, Kuo YKE, Chibnik LB, Carlyle
BC, Serrano-Pozo A, Scherzer CR, Hyman BT, Das S, Arnold SE. Plasma biomarkers
for prognosis of cognitive decline in patients with mild cognitive impairment.
Brain Commun. 2022 Jun 14;4(4):fcac155. doi: 10.1093/braincomms/fcac155. PMID:
35800899; PMCID: PMC9257670.

188: Yousaf I, Anwar F, Imtiaz S, Almadhor AS, Ishmanov F, Kim SW. An Optimized
Hyperparameter of Convolutional Neural Network Algorithm for Bug Severity
Prediction in Alzheimer's-Based IoT System. Comput Intell Neurosci. 2022 Jun
28;2022:7210928. doi: 10.1155/2022/7210928. PMID: 35800696; PMCID: PMC9256343.

189: Owona BA, Njayou FN, Mkounga P, Moundipa PF. <i>Khaya grandifoliola</i>
active fraction as a source of therapeutic compounds for Alzheimer's disease
treatment: In silico validation of identified compounds. In Silico Pharmacol.
2022 Jul 4;10(1):11. doi: 10.1007/s40203-022-00126-0. PMID: 35800001; PMCID:
PMC9253233.

190: Yokoyama M, Kobayashi H, Tatsumi L, Tomita T. Mouse Models of Alzheimer's
Disease. Front Mol Neurosci. 2022 Jun 21;15:912995. doi:
10.3389/fnmol.2022.912995. PMID: 35799899; PMCID: PMC9254908.

191: Sinnige T. Molecular mechanisms of amyloid formation in living systems.
Chem Sci. 2022 May 17;13(24):7080-7097. doi: 10.1039/d2sc01278b. PMID: 35799826;
PMCID: PMC9214716.

192: Tang Y, Zhang D, Gong X, Zheng J. Repurposing of intestinal defensins as
multi-target, dual-function amyloid inhibitors <i>via</i> cross-seeding. Chem
Sci. 2022 May 20;13(24):7143-7156. doi: 10.1039/d2sc01447e. PMID: 35799805;
PMCID: PMC9214849.

193: Koronyo-Hamaoui M, Gaire BP, Frautschy SA, Alvarez JI. Editorial: Role of
Inflammation in Neurodegenerative Diseases. Front Immunol. 2022 Jun
21;13:958487. doi: 10.3389/fimmu.2022.958487. PMID: 35799792; PMCID: PMC9253757.

194: Su Q, Dai B, Zhang H, Zhang S. Discovering Gene Signature Shared by
Prostate Cancer and Neurodegenerative Diseases Based on the Bioinformatics
Approach. Comput Math Methods Med. 2022 Jun 28;2022:8430485. doi:
10.1155/2022/8430485. PMID: 35799671; PMCID: PMC9256333.

195: Wang L, Zhou BQ, Li YH, Jiang QQ, Cong WH, Chen KJ, Wen XM, Wu ZZ.
Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective
effects in a mouse model of Alzheimer's disease. Neural Regen Res. 2023
Jan;18(1):226-232. doi: 10.4103/1673-5374.344841. PMID: 35799547; PMCID:
PMC9241388.

196: Fu XX, Duan R, Wang SY, Zhang QQ, Wei B, Huang T, Gong PY, Yan E, Jiang T,
Zhang YD. Lamotrigine protects against cognitive deficits, synapse and nerve
cell damage, and hallmark neuropathologies in a mouse model of Alzheimer's
disease. Neural Regen Res. 2023 Jan;18(1):189-193. doi:
10.4103/1673-5374.343888. PMID: 35799541; PMCID: PMC9241401.

197: Yan F, Liu J, Chen MX, Zhang Y, Wei SJ, Jin H, Nie J, Fu XL, Shi JS, Zhou
SY, Jin F. Icariin ameliorates memory deficits through regulating brain insulin
signaling and glucose transporters in 3×Tg-AD mice. Neural Regen Res. 2023
Jan;18(1):183-188. doi: 10.4103/1673-5374.344840. PMID: 35799540; PMCID:
PMC9241391.

198: Jeans AF. Hebbian plasticity: the elusive missing link at the heart of
Alzheimer's disease pathogenesis? Neural Regen Res. 2023 Jan;18(1):123-124. doi:
10.4103/1673-5374.340402. PMID: 35799525; PMCID: PMC9241428.

199: Qiu S, Palavicini JP, Han X. Myelin lipid deficiency: a new key driver of
Alzheimer's disease. Neural Regen Res. 2023 Jan;18(1):121-122. doi:
10.4103/1673-5374.343893. PMID: 35799524; PMCID: PMC9241415.

200: Kelley S, Perez-Urrutia N, Morales R. Misfolded amyloid-β strains and their
potential roles in the clinical and pathological variability of Alzheimer's
disease. Neural Regen Res. 2023 Jan;18(1):119-120. doi:
10.4103/1673-5374.340403. PMID: 35799523; PMCID: PMC9241421.